Mundipharma Announces its Digital Vision and Launches First Augmented Reality App to Help Asthma Sufferers ‘breatherite™’

Mundipharma announces vision to focus on technology and providing game-changing healthcare solutions New vision exemplified…

Read More

MUNDIPHARMA ANNOUNCES STRATEGIC PARTNERSHIP WITH KOLON LIFE SCIENCE TO MARKET INVOSSATM IN KOREA

Hailed as world’s first cell-medicated gene therapy for osteoarthritis Strategic marketing partnership to ensure reach…

Read More

Mundipharma Wins Approval for Antineoplastic Agent mundesine® as Treatment for Relapsed/Refractory Peripheral T-cell Lymphoma in Japan

Japan first market to receive approval for treatment worldwide First oral PNP inhibitor to be…

Read More

Mundipharma helps fight common colds with introduction of BETADINE® Cold Defence

A natural product with anti-viral effects further extends the BETADINE® product range A new treatment…

Read More

Innovative Game Puts Spotlight on Mundipharma’s Regional Healthcare Partnership with Manchester City

SINGAPORE, 16 February 2017 – Healthcare company Mundipharma has released the Manchester City game, ‘BETADINE®…

Read More

Mundipharma and Helsinn Group Expand Exclusive Licensing and Distribution Agreements for Leading Anti-emetic Products in Middle East, Africa, Latin America and Indonesia

Anti-emetic products covered under expanded agreements include ALOXI® and AKYNZEO Both are prophylactic agents for…

Read More

Sorry, no posts matched your criteria.

Sorry, no posts matched your criteria.

↓